Latest Corporate News
D-Wave Quantum Agrees to Acquire Quantum Circuits for $550 Million
D-Wave Quantum Inc. announced a merger agreement to acquire Quantum Circuits Inc. for $550 million in stock and cash, combining annealing and gate-model quantum technologies. The deal aims to launch commercial gate-model systems in 2026 and is expected to close in late January pending approvals. It strengthens D-Wave's leadership in superconducting quantum computing with Quantum Circuits' error-detection tech.
Merck Completes Acquisition of Cidara Therapeutics
Merck finalized its cash tender offer for Cidara Therapeutics at $221.50 per share, with the merger completing today making Cidara a wholly owned subsidiary. The deal will result in a $9.0 billion R&D expense charge in 2026, impacting earnings by $3.65 per share. Cidara's stock will cease trading on Nasdaq post-merger.
Amgen Acquires Dark Blue Therapeutics for $840 Million
Amgen kicked off 2026 with the $840 million acquisition of Dark Blue Therapeutics to enhance its oncology and metabolic pipelines amid pharma's M&A frenzy. This bolt-on deal addresses patent cliffs and IRA pressures, with analysts eyeing $3.9 trillion in global healthcare deals.
Viking Therapeutics emerges as a top target in obesity space.
Compass and Anywhere Real Estate Shareholders Approve Merger
Stockholders of Compass and Anywhere Real Estate overwhelmingly approved their merger, expected to close January 9, 2026, subject to customary conditions. The deal combines real estate tech and traditional brokerage operations.
National Bank Holdings Completes Vista Bancshares Acquisition
National Bank Holdings Corporation finalized its acquisition of Vista Bancshares Inc. and Vista Bank on January 7, 2026. This expands its regional banking footprint.
STAAR Surgical Terminates Proposed Acquisition by Alcon
STAAR Surgical ended its merger agreement with Alcon after failing to secure required stockholder approval at the January 6 meeting, following multiple delays. The original vote was set for October 2025 but postponed four times.
UK Commercial Property Deals Poised for 2026 Rebound
UK analysts predict a 10% rise in commercial real estate transactions to £55 billion in 2026 after matching 2025 levels, driven by broader deal categories. Savills noted uncertainty in 2025 but optimism ahead.
Covivio and Blue Owl Form JV for Paris Office Campuses
Covivio partnered with Blue Owl Capital in a joint venture for three Thales-occupied office campuses near Paris, valued at €503 million. The deal, closing H1 2026, generates €138 million proceeds for Covivio.
Pharma M&A Outlook: Obesity and HIV Drive Mega-Deals in 2026
Big Pharma's acquisition spree targets obesity drugs, with Viking Therapeutics and Structure Therapeutics as prime candidates amid $3.9 trillion deal flow projection. Patent cliffs and IRA impacts fuel mega-mergers between top firms.
Pfizer integrates recent $4.9B Metsera buy for obesity entry.
Global Markets Retreat on Profit-Taking, Energy Pressured by Venezuela Oil
US equities like S&P 500 fell 0.34% as financials and energy sectors dropped over 1%, hit by Trump comments on Venezuelan oil supply adding 50 million barrels. Oil prices weakened on oversupply fears.
Soren Acquisition Corp. Prices IPO Ahead of January 8 Close
Soren Acquisition Corp. priced its offering, expected to close January 8, 2026, with underwriters granted a 45-day option. This SPAC targets further mergers.